Tarsus Pharmaceuticals, Inc. (TARS) Earnings
NASDAQ·Healthcare·Biotechnology
$74.58
-3.24%
Mkt Cap $3.37B
EPS — Estimate vs Actual
Mkt Cap
$3.37B
P/E
—
Fwd P/E
—
P/S
6.29
Rev TTM
—
EPS TTM
-$1.14
NASDAQ·Healthcare·Biotechnology
$74.58
-3.24%
Mkt Cap $3.37B
Mkt Cap
$3.37B
P/E
—
Fwd P/E
—
P/S
6.29
Rev TTM
—
EPS TTM
-$1.14